ALT001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ALT001, covering 2026-03-24 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type [EARLY_Phase 1]